Corebridge Financial Inc. Decreases Stake in agilon health, inc. (NYSE:AGL)

Corebridge Financial Inc. lessened its holdings in shares of agilon health, inc. (NYSE:AGL) by 7.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 153,375 shares of the company’s stock after selling 11,577 shares during the period. Corebridge Financial Inc.’s holdings in agilon health were worth $291,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AGL. Vanguard Group Inc. grew its position in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after purchasing an additional 272,787 shares in the last quarter. Samalin Investment Counsel LLC increased its stake in shares of agilon health by 378.2% in the 4th quarter. Samalin Investment Counsel LLC now owns 60,545 shares of the company’s stock worth $115,000 after acquiring an additional 47,885 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of agilon health during the 4th quarter worth $111,000. Intech Investment Management LLC boosted its position in shares of agilon health by 99.6% during the 4th quarter. Intech Investment Management LLC now owns 115,693 shares of the company’s stock valued at $220,000 after acquiring an additional 57,726 shares during the last quarter. Finally, Signaturefd LLC increased its position in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after purchasing an additional 8,467 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AGL. Macquarie began coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price on the stock. Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a report on Friday, March 21st. Royal Bank of Canada raised their target price on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and upped their price target for the company from $3.30 to $8.50 in a research note on Tuesday. Finally, Citigroup raised agilon health from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of “Hold” and a consensus target price of $4.37.

agilon health Price Performance

agilon health stock opened at $5.52 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The firm has a market cap of $2.27 billion, a PE ratio of -5.87 and a beta of 0.38. The company’s 50 day moving average is $3.94 and its two-hundred day moving average is $3.06.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.